Wednesday, September 2, 2020

Plasmin could be the link between COVID-19 comorbidities and serious illness

A drug that inhibits the protease plasmin is hypothesized to reduce the infectivity and virulence of the virus, as measured by reduced need for hospitalization within a week.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200902131911.htm

No comments:

Post a Comment